Emerson reported a decrease in GAAP net sales by 16 percent to $3.9 billion, with underlying sales down 15 percent due to COVID-19 impacts. GAAP EPS was $0.67, a 31 percent decrease, while adjusted EPS was $0.80, exceeding management guidance due to cost reduction actions and a lower effective tax rate. The company delivered strong operating and free cash flow, initiated restructuring actions, and updated its full-year guidance as cost savings take effect and demand begins to stabilize.
GAAP net sales decreased by 16 percent, with underlying sales down 15 percent due to COVID-19 impacts.
GAAP EPS was $0.67, down 31 percent, while adjusted EPS was $0.80, exceeding guidance.
Operating cash flow was $842 million, and free cash flow was $738 million for the quarter.
Full-year guidance was updated to reflect cost savings and stabilizing demand.
Emerson updated the full year 2020 outlook to reflect the dynamic demand environment associated with global economic reopening and the stronger cost savings impacts.